Skip to main content
logo
Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.585
+0.065 (4.28%)
At close: Jul 27, 2026, 4:00 PM EDT
1.640
+0.055 (3.47%)
Pre-market: Jul 28, 2026, 7:35 AM EDT

Aldeyra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
96312298208408232
Market Cap Growth
-71.13%4.70%43.25%-49.02%75.44%-12.42%
Enterprise Value
46.12257.13211.880.61249.3618.39
Last Close Price
1.595.184.993.516.964.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-16.3213.27---
PB Ratio
2.277.044.191.732.701.13
P/TBV Ratio
2.267.034.181.732.691.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-00.210.000.100.08
Net Debt / Equity Ratio
-1.17-1.23-1.21-1.06-1.05-1.04
Net Debt / EBITDA Ratio
1.761.561.432.992.543.82
Net Debt / FCF Ratio
1.901.641.994.192.795.03
Quick Ratio
2.672.525.446.4211.3519.52
Current Ratio
2.722.585.596.6411.7819.77
Return on Equity (ROE)
-63.35%-58.73%-58.54%-27.73%-34.77%-43.56%
Return on Assets (ROA)
-40.98%-39.92%-47.54%-25.97%-30.25%-35.53%
Return on Capital Employed (ROCE)
-65.70%-54.15%-56.70%-29.31%-32.37%-38.47%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-0.94%-0.96%-0.92%-0.92%-8.07%-59.11%
Total Shareholder Return
-0.94%-0.96%-0.92%-0.92%-8.07%-59.11%
SEC Filings: 10-K · 10-Q